Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis (Q45106619)

9 December 2017

title

Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis (English)

1 reference

9 December 2017

1 reference

3

Nai-Kong V Cheung

1 reference

9 December 2017

1

Irene Y Cheung

1 reference

9 December 2017

Arvind Sahota

2

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

101

1 reference

9 December 2017

issue

10

1 reference

9 December 2017

page(s)

2303-2308

1 reference

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Detection of neuroblastoma cells in blood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

High-sensitivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Early Molecular Response of Marrow Disease to Biologic Therapy Is Highly Prognostic in Neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Significance of molecular quantification of minimal residual disease in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20660

7 January 2021

Identifiers

DOI

10.1002/CNCR.20660

1 reference

9 December 2017

1 reference